Shenzhen, Guangdong, China | Fund Name | Location |
| Bank of St. Elizabeth | Missouri, Saint Elizabeth, United States |
| Cancer Rop | - |
| Cheshire & Warrington | England, Somerset West and Taunton, United Kingdom |
| EDF Ventures | Ann Arbor, Michigan, United States |
| Frontier Equities VC | New York, New York, United States |
| Hanwha Solutions | Seoul, Seoul-t'ukpyolsi, South Korea |
| Inter American Development Bank | District of Columbia, United States, Washington |
| Iterative | Central, Central Region, Singapore |
| Kunshan Zhouyuan Electronics | China, Jiangsu, Suzhou |
| Lingo Ventures | Brooklyn, New York, United States |
| Natural Capital | California, Palo Alto, United States |
| Neon Capital | - |
| NW Brown Ventures | Cambridge, Cambridgeshire, United Kingdom |
| RocSon Medtech Fund | - |
| RSVP Capital | Ann Arbor, Michigan, United States |
| Simplex | Japan, Tokyo |
| Smarter Capital | Australia, Saint Leonards, Victoria |
| Telluride Venture Accelerator | Colorado, Telluride, United States |
| Tokyo XR Startups | Chiyoda, Japan |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
HiberGene Diagnostics | $7M | 01 Mar 2017 | Dublin |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
HiberGene Diagnostics | $7M | 01 Mar 2017 | Dublin |
